"Earlier this year, Snapdragon completed a groundbreaking photochemistry campaign for cGMP API manufacturing, making nearly 18 kg of the product with a single 5 kW Iris Max photoreactor. Making this drug for the first time in this quantity is extremely enabling and will help provide the proof many clients need to see photochemistry as efficient reliable and powerful."
Snapdragon Chemistry's innovative IRIS photoreactor platform and recent successful cGMP photochemistry scale-up were recently featured in Specialty Chemicals Magazine (Nov/Dec 2021, page 58). As stated in the article, Snapdragon continues to invest in and develop new technologies in the promising field of photochemistry. Read more at the link below for the full article!